These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38968149)

  • 1. Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.
    Thorsson H; Henningsson R; Puente-Moncada N; Peña-Martínez P; Sjöström L; Ågerstam H; Sandén C; Rissler M; Castor A; Marquart H; Modvig S; Paulsson K; Pronk CJ; Schmiegelow K; Hyrenius-Wittsten A; Orsmark-Pietras C; Lilljebjörn H; Fioretos T
    Blood; 2024 Sep; 144(13):1399-1411. PubMed ID: 38968149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Bakker M; Hoogkamer AQ; Boer JM; Hartman QJ; Stalpers F; Escherich G; de Haas V; de Groot-Kruseman HA; Pieters R; den Boer ML
    Sci Rep; 2018 Jan; 8(1):693. PubMed ID: 29330417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients.
    Gupta DG; Varma N; Naseem S; Sachdeva MUS; Bose P; Binota J; Kumar A; Gupta M; Rana P; Sonam P; Malhotra P; Trehan A; Khadwal A; Varma S
    Turk J Haematol; 2022 Feb; 39(1):1-12. PubMed ID: 34617433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
    Buldini B; Varotto E; Maurer-Granofszky M; Gaipa G; Schumich A; Brüggemann M; Mejstrikova E; Cazzaniga G; Hrusak O; Szczepanowski M; Scarparo P; Zimmermann M; Strehl S; Schinnerl D; Zaliova M; Karawajew L; Bourquin JP; Feuerstein T; Cario G; Alten J; Möricke A; Biffi A; Parasole R; Fagioli F; Valsecchi MG; Biondi A; Locatelli F; Attarbaschi A; Schrappe M; Conter V; Basso G; Dworzak MN
    Blood; 2024 Apr; 143(17):1738-1751. PubMed ID: 38215390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.
    Lilljebjörn H; Henningsson R; Hyrenius-Wittsten A; Olsson L; Orsmark-Pietras C; von Palffy S; Askmyr M; Rissler M; Schrappe M; Cario G; Castor A; Pronk CJ; Behrendtz M; Mitelman F; Johansson B; Paulsson K; Andersson AK; Fontes M; Fioretos T
    Nat Commun; 2016 Jun; 7():11790. PubMed ID: 27265895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
    Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
    Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
    Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
    Zaliova M; Stuchly J; Winkowska L; Musilova A; Fiser K; Slamova M; Starkova J; Vaskova M; Hrusak O; Sramkova L; Stary J; Zuna J; Trka J
    Haematologica; 2019 Jul; 104(7):1396-1406. PubMed ID: 30630978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures.
    Schroeder MP; Bastian L; Eckert C; Gökbuget N; James AR; Tanchez JO; Schlee C; Isaakidis K; Häupl B; Baum K; Migueles Lozano OA; Kouidri K; Pan KT; Urlaub H; Schwartz S; Burmeister T; von Stackelberg A; Hoelzer D; Pfeiffer H; Rieger MA; Göllner S; Oellerich T; Horstman M; Schrappe M; Wolf J; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Neumann M; Baldus CD
    Sci Rep; 2019 Mar; 9(1):4188. PubMed ID: 30862934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers in ALL: Clinical implications.
    Kimura S; Mullighan CG
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101193. PubMed ID: 33038982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
    Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
    Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zaliova M; Potuckova E; Hovorkova L; Musilova A; Winkowska L; Fiser K; Stuchly J; Mejstrikova E; Starkova J; Zuna J; Stary J; Trka J
    Haematologica; 2019 Jul; 104(7):1407-1416. PubMed ID: 30630977
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.
    Jeha S; Choi J; Roberts KG; Pei D; Coustan-Smith E; Inaba H; Rubnitz JE; Ribeiro RC; Gruber TA; Raimondi SC; Karol SE; Qu C; Brady SW; Gu Z; Yang JJ; Cheng C; Downing JR; Evans WE; Relling MV; Campana D; Mullighan CG; Pui CH
    Blood Cancer Discov; 2021 Jul; 2(4):326-337. PubMed ID: 34250504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
    James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
    J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
    Paietta E; Roberts KG; Wang V; Gu Z; Buck GAN; Pei D; Cheng C; Levine RL; Abdel-Wahab O; Cheng Z; Wu G; Qu C; Shi L; Pounds S; Willman CL; Harvey R; Racevskis J; Barinka J; Zhang Y; Dewald GW; Ketterling RP; Alejos D; Lazarus HM; Luger SM; Foroni L; Patel B; Fielding AK; Melnick A; Marks DI; Moorman AV; Wiernik PH; Rowe JM; Tallman MS; Goldstone AH; Mullighan CG; Litzow MR
    Blood; 2021 Sep; 138(11):948-958. PubMed ID: 33895809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia.
    Fidyt K; Pastorczak A; Goral A; Szczygiel K; Fendler W; Muchowicz A; Bartlomiejczyk MA; Madzio J; Cyran J; Graczyk-Jarzynka A; Jansen E; Patkowska E; Lech-Maranda E; Pal D; Blair H; Burdzinska A; Pedzisz P; Glodkowska-Mrowka E; Demkow U; Gawle-Krawczyk K; Matysiak M; Winiarska M; Juszczynski P; Mlynarski W; Heidenreich O; Golab J; Firczuk M
    Mol Oncol; 2019 May; 13(5):1180-1195. PubMed ID: 30861284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
    Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
    Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
    Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-read sequencing unveils IGH-DUX4 translocation into the silenced IGH allele in B-cell acute lymphoblastic leukemia.
    Tian L; Shao Y; Nance S; Dang J; Xu B; Ma X; Li Y; Ju B; Dong L; Newman S; Zhou X; Schreiner P; Tseng E; Hon T; Ashby M; Li C; Easton J; Gruber TA; Zhang J
    Nat Commun; 2019 Jun; 10(1):2789. PubMed ID: 31243274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.